saying that though, an argument would be it done precisely nothing in the pervious 12 months to Increase holders value.
CSL possible pull back to low $200's, page-33
-
-
- There are more pages in this discussion • 550 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$308.97 |
Change
0.410(0.13%) |
Mkt cap ! $149.0B |
Open | High | Low | Value | Volume |
$307.48 | $309.29 | $306.25 | $78.74M | 255.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 85 | $308.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$309.00 | 1621 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12 | 308.580 |
3 | 65 | 308.530 |
2 | 18 | 308.520 |
6 | 50 | 308.510 |
1 | 7 | 308.500 |
Price($) | Vol. | No. |
---|---|---|
308.600 | 12 | 2 |
308.620 | 4 | 1 |
308.630 | 25 | 2 |
308.640 | 14 | 1 |
308.650 | 6 | 2 |
Last trade - 12.28pm 16/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online